Defining the Most Appropriate Primary End Point in Phase 2 Trials of Immune Checkpoint Inhibitors for Advanced Solid Cancers

Defining the Most Appropriate Primary End Point in Phase 2 Trials of Immune Checkpoint Inhibitors... Key PointsQuestionWhat is the most appropriate primary end point in phase 2 trials of checkpoint inhibitors? FindingsIn this systematic review and meta-analysis of phase 2 and phase 3 trials of checkpoint inhibitors in advanced solid cancers, response rate correlated poorly with overall survival, but 6-month progression-free survival was a better predictor of 12-month overall survival. MeaningSix-month progression-free survival is recommended in place of response rate as an end point in future phase 2 checkpoint-inhibitor trials. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Defining the Most Appropriate Primary End Point in Phase 2 Trials of Immune Checkpoint Inhibitors for Advanced Solid Cancers

Loading next page...
 
/lp/jama/defining-the-most-appropriate-primary-end-point-in-phase-2-trials-of-l0BKU5f2s9
Publisher
American Medical Association
Copyright
Copyright 2018 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
D.O.I.
10.1001/jamaoncol.2017.5236
Publisher site
See Article on Publisher Site

Abstract

Key PointsQuestionWhat is the most appropriate primary end point in phase 2 trials of checkpoint inhibitors? FindingsIn this systematic review and meta-analysis of phase 2 and phase 3 trials of checkpoint inhibitors in advanced solid cancers, response rate correlated poorly with overall survival, but 6-month progression-free survival was a better predictor of 12-month overall survival. MeaningSix-month progression-free survival is recommended in place of response rate as an end point in future phase 2 checkpoint-inhibitor trials.

Journal

JAMA OncologyAmerican Medical Association

Published: Apr 22, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off